Ikhambi Lokukhulisa I-Game Universe Ngemidlalo Emisha Emibili
I-CEO ye-Remedy, u-Tero Virtala, umemezele ama-spinoff amabili okulawulwa kwegeyimu okutuswa kabi esitatimendeni sakamuva kubatshalizimali. Kuyathakazelisa ukuthi omunye wemidlalo kuzoba umdlalo we-PvE wabadlali abaningi osethwe endaweni yokulawula.
Iphrojekthi ye-PvE ibizwa nge-“Condor” futhi iyingxenye yomzamo wokusebenzisana nama-505 Games. I-505 Games ingumshicileli wokulawula igeyimu kwasekuqaleni. Ngokusho kokukhishwa kwabezindaba kwangaphambilini, i-Condor izokwenziwa ngenjini yokuphathelene ye-Remedy i-Northlight futhi ikhishwe ku-PC, PS5, i-Xbox Series X|S. Nakuba imininingwane iyingcosana, kubukeka sengathi umdlalo uzoba umdlalo we-PvE wabadlali abangu-4 obekwe emhlabeni wokulawula.
ICondor izomaka inkathi entsha yesitudiyo se-Remedy, esigxile kuphela emidlalweni yomdlali oyedwa iminyaka engaphezu kwengu-25 - ukusuka ku-Max Payne kuya ku-Alan Wake. Nakuba evuma ukuthi kungase kube nabangabaza ikhono likaRemedy lokwenza umdlalo wabadlali abaningi, uMikael Kasurinen, umqondisi wegeyimu we-Control Franchise, uzwakalisa injabulo yakhe ngokudala umuzwa wabadlali abaningi kwenye isitatimende kwabezindaba: “Sithola ukuthi kuzoba nokungabaza. mayelana nabadlali abaningi. Kodwa ngikholwa ukuthi singakha okuhlangenwe nakho okwabiwe ngaphandle kokubeka engcupheni i-DNA eyingqayizivele yokuthi singobani, noma izindaba esifuna ukuzixoxa.”
Kulabo abangathengiswa ngekhono lephrojekthi yabadlali abaningi lokuthuthukisa i-franchise, I-Remedy isezigabeni zokuqala zokuhlelela ukunwetshwa kwebhajethi enkulu ku-franchise yokulawula. Ngokungafani ne-Condor, le phrojekthi entsha cishe izoba umdlalo womdlali oyedwa. Ukulawula kwase kucishe kwamenyezelwa emhlabeni wonke ngenxa yokubonakala kwayo, i-physics, nokulwa ngo-2019 - ngakho-ke inguqulo yebhajethi enkulu yokulawula iveza ikusasa elijabulisayo le-franchise.
Ucabangani mayelana nama-spinoffs amasha okulawula? Sazise phansi kumazwana, noma usithinte Twitter or Facebook.
Okuthunyelwe Lawula ama-Spinoffs amasha Okuningiliziwe yi-CEO ye-Remedy ivele kuqala I-COGxhunyiwe.
